-
What’s Hot: FXCM Inc. (NYSE:FXCM), Flamel Technologies SA (NASDAQ:FLML), Valley National Bancorp (NYSE:VLY), Ametek Inc. (NYSE:AME), Sensata Technologies Holding NV (NYSE:ST)
Leucadia National Corp gave FXCM Inc (NYSE:FXCM) a $300 million cash infusion, extending a lifeline to the currency brokerage hobbled by the Swiss central bank’s decision to let the franc trade freely against the euro. On Friday shares of FXCM Inc. (NYSE:FXCM) closed at $1.49. Company’s sales growth for last 5 years was 8.70% and…
-
Pre-market Gainers to Watch: China Finance Online (NASDAQ:JRJC), Flamel Technologies (NASDAQ:FLML), Linn Co, (NASDAQ:LNCO), Linn Energy, LLC (NASDAQ:LINE), Merrimack Pharmaceuticals (NASDAQ:MACK)
China Finance Online Co. (ADR) (NASDAQ:JRJC) announced that it has entered into a strategic partnership agreement with China International Capital Corporation Limited (“CICC “), which is a top global securities and investment firm from China. On Wednesday shares of China Finance Online Co. (ADR) (NASDAQ:JRJC) closed at $4.79. Company’s sales growth for last 5 years…
-
Small Cap Losers: Ocwen Financial Corp. (NYSE:OCN), Arena Pharmaceuticals (NASDAQ:ARNA), Hecla Mining Co. (NYSE:HL), Flamel Technologies SA (NASDAQ:FLML), FuelCell Energy (NASDAQ:FCEL)
After receiving several complaints regarding Ocwen Financial Corp’s (NYSE:OCN) servicing of mortgages in California, state regulators started an investigation to find out if the mortgage company’s practices were in compliance to California Homeowners Bill of Rights. On Wednesday shares of Ocwen Financial Corp. (NYSE:OCN) closed at $7.00. Company’s sales growth for last 5 years was…
-
Stocks to Keep Eyes On: Flamel Technologies SA (NASDAQ:FLML), BlackBerry Ltd (NASDAQ:BBRY), Consolidated Communications Holdings (NASDAQ:CNSL), The Coca-Cola (NYSE:KO), Canadian Solar (NASDAQ:CSIQ)
Flamel Technologies SA (NASDAQ:FLML) learned the U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi’s New Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel currently markets as Bloxiverz. On Wednesday shares of Flamel Technologies SA (NASDAQ:FLML) closed at $11.50. Company’s sales growth for last 5 years was -10.30% BlackBerry Ltd (NASDAQ:BBRY) said…
-
Top Stocks: Flamel Technologies SA (NASDAQ:FLML), Rexahn Pharmaceuticals (NYSEMKT:RNN), NiSource Inc. (NYSE:NI), Energy Recovery (NASDAQ:ERII), Trinseo SA (NYSE:TSE)
Flamel Technologies (NASDAQ:FLML) learned the U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi’s New Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel currently markets as Bloxiverz. On Wednesday shares of Flamel Technologies SA (NASDAQ:FLML) closed at $11.50. Company’s sales growth for last 5 years was -10.30%. Rexahn Pharmaceuticals Inc. (NYSEMKT:RNN) Director…
-
Market Alert: Flamel Technologies SA (NASDAQ:FLML), QAD Inc. (NASDAQ:QADA), Lakeland Bancorp Inc. (NASDAQ:LBAI), GenCorp Inc. (NYSE:GY), RPC Inc. (NYSE:RES)
Roth Capital reissued their buy rating on shares of Flamel Technologies S.A. (NASDAQ:FLML) in a research note released on Thursday morning. They currently have a $22.00 target price on the stock. On Wednesday shares of Flamel Technologies SA (NASDAQ:FLML) closed at $11.50. Company’s sales growth for last 5 years was -10.30%. QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB),…
-
Stocks to Watch: Cerus Corporation (NASDAQ:CERS), International Rectifier Corporation (NYSE:IRF), Flamel Technologies SA (NASDAQ:FLML), Sun Communities Inc. (NYSE:SUI), Sequential Brands Group (NASDAQ:SQBG)
On 16 December Cerus Corporation (NASDAQ:CERS) announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma. The INTERCEPT plasma system is approved for ex vivo preparation of plasma in order to reduce the risk of transfusion-transmitted infection (TTI) when treating patients requiring therapeutic plasma transfusion. Cerus Corporation (NASDAQ:CERS)…
-
Traders Buzz: Royal Dutch Shell plc (NYSE:RDS-A), Whiting Petroleum Corp. (NYSE:WLL), Radcom (NASDAQ:RDCM), Baxter International Inc. (NYSE:BAX), Flamel Technologies SA (NASDAQ:FLML)
On January 2, Royal Dutch Shell plc (NYSE: RDS.A) (NYSE: RDS.B) announces that on 2 January, 2015 it purchased for cancellation 590,000 “A” Shares at a price of 2155.49 pence per share. Royal Dutch Shell plc (NYSE:RDS-A) in last trading activity fell -4.75% to close at $63.80. Company weekly performance is -7.43% while its quarterly…